40 h. ago Jubilant FoodWorks Shares Upgraded To 'Buy' By Dolat Capital Post Strong Q1 Results

Jubilant FoodWorks delivers strong Q1 on delivery surge and dine-In revival; Dolat Capital maintains target price.

Economics

7 d. ago 'Reduce' Page Industries Shares Maintains Dolat Capital Post Weak Q1 Results

Dolat Capital believes that revenue growth would improve with the recent price hikes and completion of ARS implementation.

Politics

8 d. ago Lupin Q1 Review: Dolat Capital Maintains 'Add', But Cuts Target Price

Timely launches of injectables and inhalation products will be further triggers to the brokerage's earnings estimates.

Events

9 d. ago 'Add' Berger Paints Shares Maintains Dolat Capital Post Q1 Results

Berger Paints gross margin expanded by 150 bps YoY to 41.4% due to favorable raw material trends and improved product mix.

Politics

9 d. ago Alembic Pharma Q1 Review: Dolat Capital Maintains 'Add', Revises Target Price

Dolat Capital maintains 'Accumulate' rating on Alembic Pharma and revises target price.

Events

3 w. ago ICICI Bank: Dolat Capital Maintains 'Buy' Post Robust Q1 Results

ICICI Bank's valuations benefit from consistently superior asset quality metrics.

Economics

4 w. ago LTIMindtree Shares: Dolat Capital Revises Rating To 'Add' Post Inline Q1 Results

Given some recent surge in price, Dolat Capital revises rating to 'Accumulate'.

Politics

4 w. ago 'Reduce' L&T Tech Shares Maintains Dolat Capital Post Q1 Results

Dolat Capital believes that growth and profitability are well built into present valuations; however, risks of macro uncertainty persist.

Politics